Market Indices
Latest News
 |
| ||
| ||
|
Price Targets
from New Street issued a price target of $13.60 for TAL on 2026-07-31 14:27:59.The adjusted price target was set to $13.60.At the time of the announcement, TAL...
July 31, 2026 TAL -1.24%
Anthony Stoss from Craig-Hallum issued a price target of $325.00 for SIMO on 2026-07-31 13:26:22.The adjusted price target was set to $325.00.At the time of the announcement, SIMO...
July 31, 2026 SIMO 6.14%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| ADXN Addex Therapeutics Ltd | 6.16
21.74% | ||||||||||||||||||
| AMTD AMTD IDEA Group | 0.80
11.96% | ||||||||||||||||||
| HIMX Himax Technologies, Inc. | 14.27
11.66% | ||||||||||||||||||
| CAN Canaan Inc. | 0.20
11.22% | ||||||||||||||||||
| UMC United Microelectronics C | 20.61
10.27% | ||||||||||||||||||
| JFIN Jiayin Group Inc. | 2.39
10.14% | ||||||||||||||||||
| KC Kingsoft Cloud Holdings L | 13.06
9.71% | ||||||||||||||||||
| SQNS Sequans Communications S. | 2.67
9.43% | ||||||||||||||||||
Annual/Quarterly Reports Summary
Summit Therapeutics Inc. (SMMT) Quarterly Report: What Does It Reveal About Their Sector Performance
May 1, 2025 SMMT 6.57%
In a landscape of rising revenues and increasing operational costs, the company navigates challenges with a focus on innovation and sustainability. Despite a dip in net income and profit declines...
February 5, 2025 SMMT 6.57%
In a year marked by resilience, the company celebrated record revenues of $25 billion, driven by strong ticket sales and operational efficiency. With a focus on North America, it reduced...
January 27, 2025 SMMT 6.57%